Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory-Reference-Cited by-同舟云学术

Development and validation of the Benzodiazepine Hypnotics Withdrawal Symptom Scale (BHWSS) based on item response theory

Published:2021-06 Issue: Volume:300 Page:113900
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Narisawa Hajime^ORCID,Inoue Yuichi,Kobayashi Mina,Okajima Isa,Kikuchi Takashi^ORCID,Kagimura Tatsuo,Matsui Kentaro,Inada Ken,Mishima Kazuo

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference24 articles.

1. International classification of sleep disorders—third edition (ICSD-3),2014

2. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial;Baillargeon;Cmaj,2003

3. FINISH: remembering the discontinuation syndrome;Berber;J. Clin. Psychiatry,1998

4. A clinical scale to assess benzodiazepine withdrawal;Busto;J Clin Psychopharmacol,1989

5. Scalability, reliability, and validity of the benzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users;Kan;Compr Psychiatry,1999

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders—a double-blind, randomized, placebo-controlled proof-of-concept study;Trials;2024-04-22

2. Clinical management of withdrawal from benzodiazepine anxiolytic and hypnotic medications;Addiction;2021-10-28